[1]
“Histopathological Evaluation of Erythropoietin’s Protective Effect Against Doxorubicin-Induced Hepatotoxicity”, AJPS, vol. 25, no. 2, pp. 192–202, May 2025, doi: 10.32947/ajps.v25i2.1150.